Steven Coutre, MD

    Steven Coutre, MD

    Professor of medicine in hematology at the Stanford University Medical Center in Stanford, California

    Drawing First Blood

    • Is Fludarabine Dead in CLL? Friday, May 1st, 2015

      Steven Coutre, MDProfessor of medicine in hematology at the Stanford University Medical Center in Stanford, CaliforniaMitchell Smith, MDDirector of the lymphoid malignancy program at the Cleveland Clinic in Cleveland, Ohio A few short years ago, fludarabine was considered the gold standard of front-line treatment for chronic lymphocytic leukemia (CLL), providing better response rates than old [...]

    back to top
    SHARE